Biochemistry Quiz: Amino Acid Catabolism And Nitrogen Handling
20 questions · exam conditions
0:00
Amino Acid Catabolism And Nitrogen HandlingQuestion 1 of 20

Tracing the metabolic journey of a nitrogen atom from a branched-chain amino acid (BCAA) in skeletal muscle to its excretion: which sequence correctly outlines the key molecules that carry this specific nitrogen atom?

BCAA → Glutamate → Alanine → Glutamate → Urea
BCAA → Glutamate → Free Ammonia → Urea
BCAA → Alanine → Pyruvate → Urea
BCAA → α-keto acid → Glutamine → Free Ammonia → Urea
← Back to quizzes

Biochemistry Quiz

Biochemistry Quiz: Amino Acid Catabolism And Nitrogen Handling

Practice Amino Acid Catabolism And Nitrogen Handling in Biochemistry with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Amino Acid Catabolism And Nitrogen Handling, giving you a quick way to practice the rules, question types, and explanations that matter most for Biochemistry.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

Tracing the metabolic journey of a nitrogen atom from a branched-chain amino acid (BCAA) in skeletal muscle to its excretion: which sequence correctly outlines the key molecules that carry this specific nitrogen atom?

  1. BCAA → Glutamate → Alanine → Glutamate → Urea (correct answer)
  2. BCAA → Glutamate → Free Ammonia → Urea
  3. BCAA → Alanine → Pyruvate → Urea
  4. BCAA → α-keto acid → Glutamine → Free Ammonia → Urea
Explanation: When you encounter questions about nitrogen metabolism, focus on the tissue-specific pathways and the body's strategy for safely transporting toxic ammonia. In skeletal muscle, branched-chain amino acids (BCAAs) undergo transamination, transferring their amino group to α-ketoglutarate to form glutamate. This glutamate then transfers its amino group to pyruvate via alanine aminotransferase, creating alanine. Alanine serves as the primary nitrogen carrier from muscle to liver via the glucose-alanine cycle. In the liver, alanine is deaminated back to glutamate, which then donates its nitrogen to urea synthesis. This gives us the sequence: BCAA → Glutamate → Alanine → Glutamate → Urea. Option A correctly captures this complete pathway. Option B (BCAA → Glutamate → Free Ammonia → Urea) misses the crucial alanine transport step - muscle doesn't release free ammonia directly due to its toxicity. Option C (BCAA → Alanine → Pyruvate → Urea) incorrectly suggests pyruvate carries nitrogen to urea synthesis, when pyruvate is the carbon skeleton left after alanine deamination. Option D (BCAA → α-keto acid → Glutamine → Free Ammonia → Urea) describes a pathway more typical of other tissues like brain or kidney, not the muscle-specific route. Remember the tissue-specific nature of nitrogen disposal: muscle uses the glucose-alanine cycle to safely transport nitrogen as alanine, while other tissues may use glutamine. Always consider which tissue the question specifies, as this determines the dominant pathway.

Question 2

A researcher is studying nitrogen metabolism in a patient with a genetic deficiency in the enzyme that synthesizes pyridoxal phosphate (PLP). This patient would likely exhibit impaired catabolism of most amino acids primarily because PLP is essential for which of the following processes?

  1. The oxidative deamination of glutamate to release free ammonia and regenerate α-ketoglutarate.
  2. The initial transfer of α-amino groups from various amino acids to α-ketoglutarate, forming glutamate. (correct answer)
  3. The hydrolysis of glutamine to glutamate and ammonia within the mitochondrial matrix of hepatocytes.
  4. The synthesis of N-acetylglutamate, the primary allosteric activator of the urea cycle.
Explanation: Pyridoxal phosphate (PLP) is the essential coenzyme for aminotransferase (transaminase) enzymes, which catalyze the transfer of an α-amino group from an amino acid to an α-keto acid, most commonly α-ketoglutarate. This is the first and most critical step in the catabolism of the majority of amino acids. A deficiency in PLP would directly impair this process. Distractor A is incorrect because oxidative deamination is catalyzed by glutamate dehydrogenase, which uses NAD⁺ or NADP⁺, not PLP. Distractor C describes the action of glutaminase, which is a hydrolase and does not require PLP. Distractor D is incorrect because N-acetylglutamate synthase does not use PLP as a cofactor.

Question 3

A patient presents with hyperammonemia following a high-protein meal. Liver biopsy reveals normal levels of all urea cycle enzymes but a significantly reduced ability to produce N-acetylglutamate (NAGS). This condition directly impairs the urea cycle because NAGS is required for which function?

  1. To allosterically activate carbamoyl phosphate synthetase I (CPS I). (correct answer)
  2. To function as a coenzyme for the argininosuccinate lyase reaction.
  3. To facilitate the transport of citrulline from the mitochondria to the cytosol.
  4. To provide the acetyl group that is ultimately incorporated into the urea molecule.
Explanation: When you encounter hyperammonemia with normal urea cycle enzymes, focus on regulatory mechanisms rather than the enzymes themselves. The urea cycle's rate-limiting step is controlled by carbamoyl phosphate synthetase I (CPS I), which requires allosteric activation to function effectively. N-acetylglutamate synthase (NAGS) produces N-acetylglutamate, the essential allosteric activator of CPS I. Without adequate NAGS activity, CPS I cannot efficiently catalyze the formation of carbamoyl phosphate from ammonia and CO₂, even when the enzyme itself is present in normal amounts. This creates a bottleneck at the very first step of the urea cycle, leading to ammonia accumulation after protein-rich meals when amino acid deamination increases ammonia production. Choice A correctly identifies this allosteric activation relationship. Choice B incorrectly assigns NAGS a coenzyme role with argininosuccinate lyase, which actually doesn't require NAGS for its function. Choice C confuses NAGS with the citrin transporter, which facilitates citrulline movement across the mitochondrial membrane—a completely separate process from NAGS function. Choice D mischaracterizes NAGS's role entirely; while NAGS does provide an acetyl group, this acetyl group activates CPS I rather than being incorporated into urea itself. Remember that NAGS deficiency is one of the few urea cycle disorders where the enzymes themselves are normal—the problem lies in enzyme regulation. When studying urea cycle disorders, always distinguish between enzyme deficiencies and regulatory defects, as they present similarly but have different underlying mechanisms.

Question 4

The carbon skeletons of amino acids are catabolized into intermediates of central metabolism. If an individual is on a diet where leucine is the sole source of energy, which outcome is expected during catabolism of its carbon skeleton?

  1. Net synthesis of oxaloacetate, supporting increased gluconeogenesis.
  2. Production of α-ketoglutarate, replenishing citric acid cycle intermediates.
  3. Formation of acetyl-CoA and acetoacetate, leading to ketone body production. (correct answer)
  4. Conversion to pyruvate, which can then be used for both gluconeogenesis and acetyl-CoA formation.
Explanation: Leucine is an exclusively ketogenic amino acid. Its carbon skeleton is broken down into acetyl-CoA and acetoacetate. Acetyl-CoA cannot be converted to pyruvate or oxaloacetate in animals, so it cannot contribute to the net synthesis of glucose. Both acetyl-CoA and acetoacetate are ketone bodies or their precursors. Therefore, a diet rich only in leucine would lead to ketosis, not gluconeogenesis. Distractors A, B, and D describe fates of glucogenic amino acids, which can be converted to pyruvate or citric acid cycle intermediates, allowing for net glucose synthesis.

Question 5

In many extrahepatic tissues, ammonia is 'fixed' into a non-toxic transport form before being sent to the liver. This process is primarily achieved by the ATP-dependent amidation of which molecule?

  1. α-ketoglutarate to form glutamine.
  2. Aspartate to form asparagine.
  3. Pyruvate to form alanine.
  4. Glutamate to form glutamine. (correct answer)
Explanation: Glutamine synthetase, an enzyme present in most peripheral tissues, catalyzes the ATP-dependent reaction of ammonia with glutamate to form glutamine. Glutamine is a major, non-toxic carrier of nitrogen in the blood, transporting two nitrogen atoms (one from the original glutamate α-amino group and one from the newly added ammonia) to the liver or kidneys. Distractor A is incorrect because amidation of α-ketoglutarate would form glutamate, a process catalyzed by glutamate dehydrogenase, not glutamine synthetase. Distractor B describes asparagine synthesis, which is a less central pathway for bulk nitrogen transport. Distractor C describes the formation of alanine via transamination, which does not directly 'fix' free ammonia and is not ATP-dependent.

Question 6

The activity of glutamate dehydrogenase, which catalyzes the release of ammonia from glutamate, is a critical control point in nitrogen metabolism. In a liver cell with a high energy charge (high ATP and GTP), what is the expected effect on this enzyme and the subsequent metabolic flux?

  1. The enzyme is allosterically activated, increasing ammonia production to fuel the urea cycle and promote amino acid synthesis.
  2. The enzyme is allosterically inhibited, conserving amino acid carbon skeletons for anabolic pathways and reducing ammonia release. (correct answer)
  3. The enzyme's activity is unchanged, as it is primarily regulated by the availability of its substrates, glutamate and NAD⁺.
  4. The enzyme shifts its preferred cofactor from NAD⁺ to NADP⁺, favoring the reductive amination of α-ketoglutarate instead of deamination.
Explanation: Glutamate dehydrogenase is allosterically inhibited by high levels of ATP and GTP, which signal a high energy state in the cell. When energy is abundant, there is less need to oxidize amino acid carbon skeletons for fuel. Therefore, inhibiting this enzyme conserves these skeletons for protein synthesis and other anabolic processes, and it reduces the production of ammonia. Distractor A incorrectly states the enzyme is activated. Distractor C ignores the well-established allosteric regulation of this enzyme. Distractor D describes the reverse reaction, which is favored under different conditions, but the primary regulatory effect of high ATP/GTP is inhibition of the oxidative deamination reaction.

Question 7

During prolonged fasting, the glucose-alanine cycle becomes highly active. Which statement accurately describes a key event in this cycle that links muscle and liver metabolism?

  1. Alanine is transported from the liver to the muscle, where it is converted to pyruvate to enter the muscle's citric acid cycle for energy.
  2. The liver deaminates alanine to pyruvate for gluconeogenesis and transfers the amino group to the urea cycle for excretion. (correct answer)
  3. Muscle tissue synthesizes alanine from pyruvate and free ammonia released directly from amino acid deamination within the muscle cell.
  4. The nitrogen from muscle protein breakdown is first transferred to α-ketoglutarate, which is then converted to alanine for transport.
Explanation: In the glucose-alanine cycle, muscle breaks down protein and transfers the amino groups to pyruvate (derived from glycolysis) to form alanine. Alanine is transported to the liver. In the liver, alanine aminotransferase (ALT) removes the amino group, converting alanine back to pyruvate. This pyruvate is a key substrate for gluconeogenesis, and the amino group is funneled into the urea cycle. Distractor A has the direction of transport reversed. Distractor C is incorrect because the nitrogen is not from free ammonia but is transferred from other amino acids to pyruvate via transamination. Distractor D is incorrect because the nitrogen is transferred to pyruvate to form alanine, not to α-ketoglutarate (which would form glutamate).

Question 8

A defect in ornithine transcarbamoylase (OTC), a mitochondrial urea cycle enzyme, is a common cause of hyperammonemia. A patient with this deficiency would be expected to have elevated levels of which molecule in their mitochondria, which then may spill into the cytosol and blood?

  1. Citrulline, because it is the product of the blocked enzymatic step.
  2. Arginine, because the cycle is unable to regenerate ornithine.
  3. Carbamoyl phosphate, as its synthesis precedes the OTC step. (correct answer)
  4. Urea, because the cycle is attempting to compensate by increasing flux through other pathways.
Explanation: Ornithine transcarbamoylase (OTC) catalyzes the reaction between carbamoyl phosphate and ornithine to form citrulline within the mitochondria. If OTC is deficient, its substrates, carbamoyl phosphate and ornithine, will accumulate. Carbamoyl phosphate, synthesized in the preceding step by CPS I, will build up significantly in the mitochondria and can then enter the pyrimidine synthesis pathway in the cytosol, leading to increased orotic acid in the urine. Distractor A is incorrect because citrulline is the product of the OTC reaction, so its levels would be low. Distractor B is incorrect because arginine is formed late in the cycle and its levels would likely be low. Distractor D is incorrect as urea production would be severely impaired.

Question 9

A researcher uses a specific inhibitor that blocks the mitochondrial ornithine/citrulline transporter. In an active liver cell carrying out urea synthesis, what would be the immediate consequence of this inhibition?

  1. Accumulation of citrulline in the cytosol and depletion of mitochondrial ornithine.
  2. Accumulation of argininosuccinate in the mitochondria due to substrate backup.
  3. Accumulation of citrulline in the mitochondria and depletion of cytosolic aspartate.
  4. Accumulation of citrulline in the mitochondria and impaired synthesis of argininosuccinate. (correct answer)
Explanation: The urea cycle is compartmentalized. Citrulline is synthesized from ornithine and carbamoyl phosphate in the mitochondria. It is then transported to the cytosol by the ornithine/citrulline transporter. In the cytosol, it reacts with aspartate to form argininosuccinate. If the transporter is blocked, citrulline cannot exit the mitochondria and will accumulate there. Consequently, the cytosolic steps, beginning with the argininosuccinate synthetase reaction, will be impaired due to a lack of the citrulline substrate. Distractor A has the locations of accumulation/depletion reversed. Distractor B is incorrect because argininosuccinate is synthesized in the cytosol. Distractor C is incorrect because cytosolic aspartate levels would not be directly depleted by this specific transport block.

Question 10

Individuals with untreated phenylketonuria (PKU) accumulate high levels of phenylalanine and its metabolite, phenylpyruvate. Phenylpyruvate is known to inhibit the pyruvate dehydrogenase complex in the brain. This specific inhibition likely contributes to neurological damage by directly impairing which process?

  1. The transport of ammonia from the brain to the liver via glutamine synthesis.
  2. The synthesis of neurotransmitters derived from tyrosine, such as dopamine.
  3. The conversion of pyruvate to acetyl-CoA, reducing substrate for the citric acid cycle. (correct answer)
  4. The gluconeogenic conversion of pyruvate to oxaloacetate via pyruvate carboxylase.
Explanation: The pyruvate dehydrogenase (PDH) complex catalyzes the irreversible conversion of pyruvate to acetyl-CoA, linking glycolysis to the citric acid cycle. The brain relies heavily on glucose oxidation for its energy. If phenylpyruvate inhibits the PDH complex, the brain's ability to generate acetyl-CoA from glucose will be severely diminished, leading to reduced flux through the citric acid cycle and a major energy deficit, which contributes to neurological damage. While neurotransmitter synthesis (B) is also impaired in PKU (due to competition for transport and tyrosine deficiency), the question specifically asks about the consequence of PDH inhibition. Distractor A is related to ammonia toxicity, not PKU. Distractor D describes the first step of gluconeogenesis, which is not the primary energy pathway in the brain.

Question 11

Under which of the following physiological conditions would an individual be expected to be in a state of negative nitrogen balance?

  1. A healthy adult consuming a protein-rich diet that meets their caloric needs.
  2. A growing child consuming adequate protein and calories for their developmental stage.
  3. An individual recovering from major surgery with a high-protein nutritional support regimen.
  4. An individual with a severe, untreated systemic infection and inadequate nutritional intake. (correct answer)
Explanation: Negative nitrogen balance occurs when nitrogen excretion is greater than nitrogen intake. This signifies that the body is breaking down more protein (net catabolism) than it is synthesizing. Severe infection triggers a catabolic stress response, where muscle protein is broken down to provide amino acids for gluconeogenesis and the synthesis of acute-phase proteins. Combined with inadequate intake, this leads to a significant net loss of body protein and a negative nitrogen balance. The other three options describe states of zero nitrogen balance (A) or positive nitrogen balance (B and C), where net protein synthesis is occurring.

Question 12

Aspartate aminotransferase (AST) is an enzyme that interconverts aspartate and α-ketoglutarate with oxaloacetate and glutamate. The reaction is freely reversible. In a hepatocyte actively engaged in gluconeogenesis from amino acid precursors, what is the predominant net direction of the AST-catalyzed reaction?

  1. Aspartate + α-ketoglutarate → Oxaloacetate + Glutamate (correct answer)
  2. Oxaloacetate + Glutamate → Aspartate + α-ketoglutarate
  3. The reaction will be at equilibrium with no net directional flux.
  4. The enzyme will primarily catalyze the deamination of aspartate to fumarate.
Explanation: During gluconeogenesis from amino acids, the goal is to produce precursors for glucose synthesis, primarily oxaloacetate (OAA). Many amino acids are catabolized to glutamate. Aspartate is also a source of carbon skeletons. The AST reaction running in the direction of Aspartate → Oxaloacetate provides OAA directly for the gluconeogenic pathway. Simultaneously, the glutamate produced can be deaminated to regenerate α-ketoglutarate and provide ammonia for the urea cycle. Thus, to support gluconeogenesis, the net flux is towards OAA production. The reverse reaction (B) is used to synthesize aspartate or to move reducing equivalents in the malate-aspartate shuttle, but not for net gluconeogenesis from aspartate.

Question 13

During amino acid catabolism, the amino groups must be safely converted to urea for excretion. A patient with hyperammonemia shows elevated glutamine levels in blood and cerebrospinal fluid. If the primary defect is in carbamoyl phosphate synthetase I (CPS-I), which of the following explains why glutamine levels are elevated rather than other amino acids?

  1. CPS-I deficiency reduces urea cycle flux, causing ammonia accumulation that drives glutamine synthetase to convert glutamate plus ammonia to glutamine as a detoxification mechanism, particularly in brain and muscle tissue (correct answer)
  2. Loss of CPS-I function impairs the malate-aspartate shuttle, leading to cytoplasmic accumulation of glutamine that cannot be transported into mitochondria for normal catabolism
  3. CPS-I normally uses glutamine as a nitrogen donor for carbamoyl phosphate synthesis, so enzyme deficiency prevents glutamine utilization and causes its accumulation in blood
  4. The defective enzyme causes feedback activation of glutaminase in kidney and liver, leading to excessive glutamine production from glutamate as compensation for reduced urea synthesis
Explanation: CPS-I catalyzes the first step of the urea cycle, combining ammonia, CO₂, and ATP to form carbamoyl phosphate. When this enzyme is deficient, ammonia accumulates because the urea cycle cannot function properly. Glutamine synthetase serves as a major detoxification mechanism by combining glutamate with ammonia to form glutamine, effectively sequestering toxic ammonia. This is particularly important in brain tissue where ammonia toxicity is dangerous. Choice B is incorrect because the malate-aspartate shuttle is not directly related to CPS-I function. Choice C is wrong because CPS-I uses ammonia (not glutamine) as the nitrogen source. Choice D is incorrect because glutaminase would be inhibited (not activated) when ammonia levels are high.

Question 14

A clinical biochemistry laboratory is investigating a patient with suspected ornithine transcarbamylase (OTC) deficiency. The patient shows hyperammonemia and elevated orotic acid excretion in urine.

Which of the following best explains the biochemical basis for the elevated orotic acid excretion in this patient, and what does this suggest about the cellular response to the enzyme deficiency?

  1. Deficient arginine production from the incomplete urea cycle reduces nitric oxide synthesis, causing compensatory activation of pyrimidine metabolism and subsequent orotic acid accumulation
  2. The hyperammonemia stimulates glutamine synthesis, which provides increased nitrogen for de novo purine synthesis, and orotic acid accumulates as a byproduct of the purine biosynthetic pathway
  3. Accumulated carbamoyl phosphate from the defective urea cycle enters the cytoplasm and is utilized by carbamoyl phosphate synthetase II for pyrimidine synthesis, leading to overproduction of orotic acid as an intermediate (correct answer)
  4. Elevated ammonia levels directly inhibit orotate phosphoribosyltransferase, preventing conversion of orotic acid to orotidine monophosphate and causing orotic acid to accumulate and be excreted
Explanation: When you encounter questions about urea cycle disorders, focus on understanding how metabolic intermediates can "spill over" into alternative pathways when their normal route is blocked. In OTC deficiency, ornithine transcarbamylase cannot efficiently convert carbamoyl phosphate and ornithine to citrulline in the mitochondria. This creates a bottleneck where carbamoyl phosphate accumulates in the mitochondria and then leaks into the cytoplasm. Once in the cytoplasm, this excess carbamoyl phosphate becomes substrate for carbamoyl phosphate synthetase II, the rate-limiting enzyme in de novo pyrimidine synthesis. The increased flux through the pyrimidine pathway leads to overproduction of orotic acid, an intermediate that gets excreted in large quantities. Answer A incorrectly suggests the mechanism involves nitric oxide synthesis and compensatory pyrimidine activation, but orotic acid elevation is direct substrate overflow, not compensation. Answer B confuses the pathway - while hyperammonemia does stimulate glutamine synthesis, orotic acid is not a byproduct of purine synthesis; it's specific to pyrimidine metabolism. Answer D describes direct ammonia inhibition of orotate phosphoribosyltransferase, but this isn't the primary mechanism - the issue is upstream overproduction of orotic acid, not downstream blockade. The correct answer is C because it accurately describes the substrate overflow mechanism: accumulated carbamoyl phosphate from the blocked urea cycle diverts into cytoplasmic pyrimidine synthesis. Study tip: Remember that urea cycle disorders often cause "metabolic spillover" - when one pathway is blocked, accumulated intermediates find alternative routes, creating unexpected metabolic signatures.

Question 15

A research team is studying the tissue-specific differences in amino acid metabolism. They observe that during exercise, muscle tissue releases alanine and glutamine into the bloodstream, while the liver takes up these amino acids. Which of the following best describes the metabolic logic underlying this inter-organ amino acid cycling?

  1. Muscle uses branched-chain amino acid catabolism to generate alanine and glutamine for energy, while liver converts these back to glucose through gluconeogenesis to maintain blood glucose during exercise
  2. Muscle proteolysis during exercise produces amino acids that are converted to alanine and glutamine for safe nitrogen transport to liver, where they undergo deamination and the nitrogen enters the urea cycle (correct answer)
  3. Exercise-induced lactate production in muscle is converted to alanine through transamination, and glutamine synthesis removes excess ammonia, with both serving as nitrogen carriers to liver for disposal
  4. Muscle releases alanine and glutamine to signal the liver to increase gluconeogenesis and glycogenolysis, with these amino acids serving primarily as hormonal messengers rather than metabolic substrates
Explanation: During exercise, muscle protein breakdown provides amino acids for energy and glucose production. However, direct deamination in muscle would produce toxic ammonia. Instead, muscle transfers amino groups to pyruvate (forming alanine) and to glutamate (forming glutamine), creating non-toxic nitrogen carriers. These are transported to liver where they can be safely deaminated, with nitrogen entering the urea cycle and carbon skeletons used for gluconeogenesis. Choice A is partially correct but misses the key nitrogen transport function. Choice C incorrectly suggests lactate is directly converted to alanine (the carbon comes from pyruvate). Choice D is wrong because alanine and glutamine are primarily metabolic substrates, not signaling molecules.

Question 16

A graduate student is studying the integration of amino acid catabolism with other metabolic pathways. The student notes that several amino acids can be converted to acetyl-CoA or acetoacetyl-CoA during their catabolism. Which of the following scenarios would most likely result in the preferential channeling of ketogenic amino acids toward ketone body synthesis rather than fatty acid synthesis?

  1. High insulin levels with abundant glucose availability, promoting acetyl-CoA carboxylase activity and creating favorable conditions for fatty acid synthesis from amino acid-derived acetyl-CoA
  2. Exercise conditions with elevated AMP levels that activate both acetyl-CoA carboxylase through AMPK and HMG-CoA synthase, promoting simultaneous fatty acid and ketone body synthesis
  3. Fed state conditions with high citrate levels that activate acetyl-CoA carboxylase while simultaneously providing substrate for both fatty acid and ketone body synthesis pathways
  4. Prolonged fasting with elevated glucagon and low insulin, leading to inhibition of acetyl-CoA carboxylase and activation of HMG-CoA synthase, favoring ketogenesis over lipogenesis (correct answer)
Explanation: When you encounter questions about amino acid catabolism and metabolic pathway integration, focus on the hormonal and energetic conditions that favor different fates for acetyl-CoA. The key insight is understanding when cells prioritize energy production (ketogenesis) versus energy storage (lipogenesis). During prolonged fasting, your body shifts from anabolic to catabolic metabolism. Elevated glucagon and low insulin create a hormonal environment that inhibits acetyl-CoA carboxylase (the rate-limiting enzyme for fatty acid synthesis) while activating HMG-CoA synthase (essential for ketone body production). This metabolic switch ensures that acetyl-CoA derived from ketogenic amino acid catabolism is channeled toward ketone bodies, which serve as an alternative fuel source for the brain and other tissues when glucose is scarce. Answer D correctly describes this fasting scenario. Answer A is incorrect because high insulin and glucose availability promote anabolic conditions favoring fatty acid synthesis, not ketogenesis. Answer B contains a fundamental error—AMPK actually inhibits acetyl-CoA carboxylase during exercise, reducing fatty acid synthesis rather than promoting it. Answer C describes fed-state conditions where high citrate levels activate acetyl-CoA carboxylase, favoring lipogenesis over ketogenesis. Remember this pattern: fasting conditions (high glucagon, low insulin) favor ketogenesis, while fed conditions (high insulin, abundant nutrients) favor lipogenesis. The reciprocal regulation of acetyl-CoA carboxylase and HMG-CoA synthase ensures acetyl-CoA is directed toward the metabolically appropriate pathway based on your body's current energy state.

Question 17

A researcher is studying amino acid catabolism in liver cells under different nutritional states. During prolonged fasting, several amino acids are deaminated to provide carbon skeletons for gluconeogenesis.

Which of the following amino acids would contribute most directly to glucose production through conversion to oxaloacetate, and what is the key intermediate formed during this process?

  1. Alanine, which forms pyruvate that is then carboxylated by pyruvate carboxylase to produce oxaloacetate in the presence of acetyl-CoA as an allosteric activator
  2. Aspartate, which undergoes transamination with α-ketoglutarate to directly form oxaloacetate while simultaneously producing glutamate for further nitrogen processing (correct answer)
  3. Serine, which is deaminated to form phosphoenolpyruvate that is then converted to oxaloacetate through the reversal of the PEPCK reaction using GTP
  4. Glycine, which is converted through the glycine cleavage system to form malate that enters the citric acid cycle and is subsequently converted to oxaloacetate
Explanation: Aspartate is directly converted to oxaloacetate through transamination with α-ketoglutarate, catalyzed by aspartate aminotransferase. This is the most direct route to oxaloacetate formation from an amino acid. Choice A describes alanine metabolism correctly (alanine → pyruvate → oxaloacetate) but this is less direct than aspartate. Choice C is incorrect because serine is deaminated to pyruvate, not PEP, and PEPCK normally converts oxaloacetate to PEP (not the reverse). Choice D is wrong because glycine cleavage produces CO₂, NH₃, and one-carbon units, not malate.

Question 18

A patient with phenylketonuria (PKU) maintained on a low-phenylalanine diet shows normal growth but elevated levels of phenylpyruvate and phenyllactate in urine. A nutritionist notes that the patient's tyrosine levels are at the low end of normal range. Which of the following adjustments would most effectively address both the elevated metabolites and the marginal tyrosine status?

  1. Increase dietary tyrosine supplementation while maintaining strict phenylalanine restriction, as this will provide the essential aromatic amino acid without contributing to phenylpyruvate formation
  2. Increase overall protein intake with emphasis on non-aromatic amino acids to dilute phenylalanine concentration while providing substrates for tyrosine synthesis through transamination reactions
  3. Implement periodic fasting intervals to reduce overall amino acid load and allow clearance of accumulated phenylpyruvate while stimulating tyrosine synthesis from alternative pathways
  4. Add tetrahydrobiopterin supplementation to enhance residual phenylalanine hydroxylase activity, potentially reducing phenylalanine accumulation while increasing endogenous tyrosine production (correct answer)
Explanation: When you encounter PKU questions, focus on the underlying enzyme deficiency and how different interventions address the metabolic block. PKU results from deficient phenylalanine hydroxylase, which normally converts phenylalanine to tyrosine using tetrahydrobiopterin (BH4) as a cofactor. The elevated phenylpyruvate and phenyllactate indicate phenylalanine is being shunted into alternative pathways due to the metabolic block. Low-normal tyrosine suggests insufficient conversion from phenylalanine, creating a secondary deficiency of this now-essential amino acid. Option D is correct because tetrahydrobiopterin supplementation can enhance whatever residual phenylalanine hydroxylase activity remains (most PKU patients retain some enzyme function). This directly addresses the root problem by improving the primary metabolic pathway, reducing phenylalanine accumulation and increasing endogenous tyrosine production simultaneously. Option A fails because simply adding tyrosine doesn't address the fundamental issue of phenylalanine accumulation and continued shunting to toxic metabolites. Option B is problematic because increasing overall protein intake would likely increase phenylalanine load, and transamination reactions cannot synthesize tyrosine from non-aromatic amino acids—you need the aromatic ring structure. Option C is counterproductive since fasting would promote protein catabolism, potentially worsening phenylalanine levels, and alternative tyrosine synthesis pathways don't exist in humans. Remember that PKU management isn't just about restricting phenylalanine—it's about optimizing the deficient metabolic pathway. Look for interventions that address the enzyme deficiency itself, particularly BH4 supplementation in responsive patients.

Question 19

A biochemistry student is analyzing the fate of nitrogen from different amino acids during catabolism. The student notes that some amino acids contribute nitrogen directly to urea synthesis while others require additional processing steps. Which of the following correctly describes the nitrogen flow from histidine catabolism to urea formation?

  1. Histidine is deaminated by histidase to form urocanate, releasing ammonia that directly enters the mitochondrial urea cycle through carbamoyl phosphate synthetase I
  2. Histidine undergoes transamination to form imidazolepyruvate, which is further catabolized to glutamate, allowing nitrogen transfer to aspartate for urea cycle entry
  3. Histidine is converted through formiminoglutamate to glutamate, which then transfers its amino group to oxaloacetate to form aspartate that provides nitrogen for urea synthesis (correct answer)
  4. Histidine catabolism produces N⁵-formyltetrahydrofolate and glutamate, with the glutamate serving as an amino donor in transamination reactions that ultimately feed nitrogen into the urea cycle
Explanation: Histidine catabolism proceeds through several steps: histidine → urocanate → 4-imidazolone-5-propionate → formiminoglutamate (FIGLU) → glutamate. The glutamate formed can then undergo transamination with oxaloacetate (catalyzed by aspartate aminotransferase) to form aspartate, which provides one of the nitrogen atoms for urea synthesis. Choice A is incorrect because histidase produces urocanate and ammonia, but the pathway continues rather than releasing ammonia directly. Choice B is wrong because histidine doesn't undergo transamination to imidazolepyruvate. Choice D is partially correct about glutamate formation but incorrectly emphasizes the one-carbon metabolism aspect over the nitrogen transfer.

Question 20

A patient with a rare genetic disorder shows elevated levels of branched-chain amino acids (leucine, isoleucine, valine) in blood and urine, along with a characteristic maple syrup odor. Analysis reveals deficient activity of the branched-chain α-keto acid dehydrogenase complex. Which of the following best explains the metabolic consequence that directly leads to the observed phenotype?

  1. Accumulation of branched-chain α-keto acids, which are then converted to branched-chain hydroxy acids and excreted, producing the distinctive odor while causing amino acid elevation through feedback inhibition of transamination (correct answer)
  2. Defective urea cycle function due to insufficient α-ketoglutarate production, leading to impaired nitrogen disposal and subsequent accumulation of branched-chain amino acids in tissues and blood
  3. Reduced gluconeogenesis from amino acid precursors, causing metabolic acidosis that inhibits branched-chain aminotransferases and prevents normal catabolism of these amino acids
  4. Impaired synthesis of essential cofactors required for amino acid metabolism, particularly thiamine pyrophosphate, leading to generalized dysfunction of amino acid catabolic pathways
Explanation: This describes maple syrup urine disease (MSUD). The branched-chain α-keto acid dehydrogenase complex normally oxidizes the α-keto acids produced from transamination of leucine, isoleucine, and valine. When this complex is deficient, the α-keto acids accumulate and are reduced to hydroxy acids or undergo other reactions that produce the characteristic odor compounds. The accumulation also causes feedback inhibition of the transamination step, leading to elevated levels of the parent amino acids. Choice B is incorrect because the urea cycle is not directly affected. Choice C is wrong because gluconeogenesis defects don't cause this specific pattern. Choice D is incorrect because the problem is with the dehydrogenase complex itself, not cofactor synthesis.